HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Human Immunodeficiency Virus and Heart Failure in Low- and Middle-Income Countries.

Abstract
Successful combination therapy for human immunodeficiency virus (HIV) has transformed this disease from a short-lived infection with high mortality to a chronic disease associated with increasing life expectancy. This is true for high- as well as low- and middle-income countries. As a result of this increased life expectancy, people living with HIV are now at risk of developing other chronic diseases associated with aging. Heart failure has been common among people living with HIV in the eras of pre- and post- availability of antiretroviral therapy; however, our current understanding of the pathogenesis and approaches to management have not been systematically addressed. HIV may cause heart failure through direct (e.g., viral replication, mitochondrial dysfunction, cardiac autoimmunity, autonomic dysfunction) and indirect (e.g., opportunistic infections, antiretroviral therapy, alcohol abuse, micronutrient deficiency, tobacco use) pathways. In low- and middle-income countries, 2 large observational studies have recently reported clinical characteristics and outcomes in these patients. HIV-associated heart failure remains a common cardiac diagnosis in people living with heart failure, yet a unifying set of diagnostic criteria is lacking. Treatment patterns for heart failure fall short of society guidelines. Although there may be promise in cardiac glycosides for treating heart failure in people living with HIV, clinical studies are needed to validate in vitro findings. Owing to the burden of HIV in low- and middle-income countries and the concurrent rise of traditional cardiovascular risk factors, strategic and concerted efforts in this area are likely to impact the care of people living with HIV around the globe.
AuthorsGerald S Bloomfield, Fawaz Alenezi, Felix A Barasa, Rebecca Lumsden, Bongani M Mayosi, Eric J Velazquez
JournalJACC. Heart failure (JACC Heart Fail) Vol. 3 Issue 8 Pg. 579-90 (Aug 2015) ISSN: 2213-1787 [Electronic] United States
PMID26251085 (Publication Type: Journal Article, Review)
CopyrightCopyright © 2015 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Topics
  • Age Factors
  • Antiretroviral Therapy, Highly Active
  • Cause of Death
  • Chronic Disease (epidemiology, mortality)
  • Cross-Sectional Studies
  • Developed Countries
  • Developing Countries
  • Forecasting
  • HIV Infections (drug therapy, epidemiology, mortality)
  • Heart Failure (epidemiology, mortality)
  • Humans
  • Internationality
  • Life Expectancy (trends)
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: